These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8389270)

  • 21. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
    Jin Y; Burns FJ; Garte SJ
    Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined erbB gene overexpression and decreased H-ras gene expression in human gliomas.
    Patt S; Cervós-Navarro J
    Acta Histochem Suppl; 1992; 42():131-8. PubMed ID: 1584958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
    Castresana JS; Barrios C; Gómez L; Kreicbergs A
    Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M; Volling P
    HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].
    Sun H; Wu S; Ouyang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):289-91. PubMed ID: 11776895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
    Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of Ha-ras and c-myc mRNA levels in rabbit embryo and extraembryonic tissues by quantitative in situ hybridization.
    Martinoli MG; Lambert RD; Pothier F; Pelletier G
    Mol Reprod Dev; 1992 Jan; 31(1):1-8. PubMed ID: 1562321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors.
    Giefing M; Wierzbicka M; Rydzanicz M; Cegla R; Kujawski M; Szyfter K
    Neoplasma; 2008; 55(1):55-60. PubMed ID: 18190242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.
    Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ
    Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
    Katsaros D; Theillet C; Zola P; Louason G; Sanfilippo B; Isaia E; Arisio R; Giardina G; Sismondi P
    Anticancer Res; 1995; 15(4):1501-10. PubMed ID: 7654038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical and molecular biological aspects of stomach cancer development in human and animal].
    Khanson KP; Kalinovskiĭ VP; Novikov LB; Fedorov SN
    Vopr Med Khim; 1991; 37(6):84-8. PubMed ID: 1812623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
    Nikiforova IF
    Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogene amplification and expression in pediatric solid tumors.
    Mares J; Polanská V; Görgens H; Sedlácek Z; Maríková T; Bocek P; Kodet R; Schackert J; Goetz P
    Neoplasma; 1998; 45(3):123-7. PubMed ID: 9717522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.